Friday, 2 June 2023
Torrent Pharmaceuticals
Revenue up 16.9% at Rs 2,491 crore (Bloomberg estimate: Rs 2,474.3 crore)
Ebitda up 29.6% at Rs 727 crore (Bloomberg estimate: Rs 728.6 crore)
Ebitda margin at 29.2% vs 26.3% (Bloomberg estimate: 29.4%)
Net profit of Rs 287 crore vs net loss of Rs 118 crore (Bloomberg estimate: Rs 322.2 crore profit) The board approved raising Rs 5,000 crore via crore via debt.
The company will pay a final dividend of Rs 8 per share for the fiscal 2023.
India Daybook – Stocks in News
*P&G:* Net profit up 36.5% Rs 210.7 cr, Revenue up 8.9% at Rs 1,138.4 cr YoY *TVS Motors:* Net profit at Rs 536.6 cr vs poll Rs 520.0 c...
-
The public sector lender has revised its marginal cost of fund-based lending rate (MCLR) with effect from November 1 in terms of the pricing...
-
he FMCG company has reported a 36 percent on-year growth in net profit at Rs 211 crore for the quarter ended September FY24 (Q1 FY24), led b...
-
India's Q4FY23 GDP growth rate was 6.1%, compared to the projected 5% growth. Q1 was 13.5%. Q2 was 6.3%. Q3 was 4.4%. The RBI's FY23...